<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>SIGNIFICANCE: Mitochondria are the cellular energy producing organelles and are at the crossroad of determining cell life and <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>As such, the function of mitochondria has been intensely studied in <z:e sem="disease" ids="C0025517" disease_type="Disease or Syndrome" abbrv="">metabolic disorders</z:e> including <z:mp ids='MP_0002055'>diabetes</z:mp> and associated maladies commonly grouped under <z:hpo ids='HP_0000001'>all</z:hpo>-inclusive pathological condition of <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>More recently, the altered metabolic profiles and function of mitochondria in these ailments has been correlated with their aberrant <z:mp ids='MP_0000002'>morphologies</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>This review describes an overview of <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> fission and fusion machineries, and discusses implications of <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> <z:mp ids='MP_0000002'>morphology</z:mp> and function in these metabolic maladies </plain></SENT>
<SENT sid="4" pm="."><plain>RECENT ADVANCES: Mitochondria undergo frequent morphological changes, altering the <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> network organization in response to environmental cues, termed '<z:hpo ids='HP_0001427'>mitochondrial</z:hpo> dynamics' </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0001427'>Mitochondrial</z:hpo> fission and fusion mediate morphological plasticity of mitochondria and controlled by membrane remodeling mechanochemical enzymes and accessory proteins </plain></SENT>
<SENT sid="6" pm="."><plain>Growing evidence suggests that <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> dynamics play an important role in <z:mp ids='MP_0002055'>diabetes</z:mp> establishment and progression as well as associated ailments, including but not limited to metabolism-secretion coupling in pancreas, non-alcoholic <z:hpo ids='HP_0001397'>fatty liver</z:hpo> disease progression, and diabetic <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>CRITICAL ISSUES: While <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> dynamics are intimately associated with <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> bioenergetics, their cause-and-effect correlation remains undefined in <z:e sem="disease" ids="C0025517" disease_type="Disease or Syndrome" abbrv="">metabolic diseases</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>FUTURE DIRECTIONS: The involvement of <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> dynamics in <z:e sem="disease" ids="C0025517" disease_type="Disease or Syndrome" abbrv="">metabolic diseases</z:e> is in its relatively early stages </plain></SENT>
<SENT sid="9" pm="."><plain>Elucidating the role of <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> dynamics in pathological metabolic conditions will aid in defining the intricate form-function correlation of mitochondria in metabolic pathologies and should provide not only important clues to <z:e sem="disease" ids="C0025517" disease_type="Disease or Syndrome" abbrv="">metabolic disease</z:e> progression but also new therapeutic targets </plain></SENT>
</text></document>